This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: Epsilon Molecular Engineering Inc.. Active years: 2020-2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020-2023
Title: Yuta Matsukawa: Innovator in High-Speed In Vitro Screening Methods
Introduction
Yuta Matsukawa is a prominent inventor based in Saitama, Japan. He has made significant contributions to the field of molecular engineering, particularly in the development of high-speed in vitro screening methods. With a total of 2 patents to his name, Matsukawa is recognized for his innovative approaches to antibody identification and molecular detection.
Latest Patents
Matsukawa's latest patents focus on high-speed in vitro screening methods. The first patent aims to provide a method for identifying antibody CDR3 clusters using a high-speed in vitro screening process. This method involves preparing positive and negative spherical shaped structures, binding target molecules, and utilizing fluorescence cell sorting for separation and analysis. The second patent also addresses high-speed in vitro screening for libraries, detailing steps for preparing spherical structures, bonding target detection molecules, and sorting conjugates for PCR amplification.
Career Highlights
Yuta Matsukawa is currently employed at Epsilon Molecular Engineering Inc., where he continues to advance his research and development efforts. His work has been instrumental in enhancing the efficiency of molecular screening techniques, which are crucial for various applications in biotechnology and pharmaceuticals.
Collaborations
Matsukawa collaborates with notable colleagues, including Naoto Nemoto and Toshiki Miyajima. Their combined expertise contributes to the innovative projects at Epsilon Molecular Engineering Inc.
Conclusion
Yuta Matsukawa is a key figure in the field of molecular engineering, with a focus on high-speed in vitro screening methods. His contributions are paving the way for advancements in antibody identification and molecular detection technologies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile